Cellect Biotechnology Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating income was ILS 2.530 million compared to ILS 5.233 million a year ago. Net loss was ILS 1.633 million compared to ILS 4.812 million a year ago. Basic loss per share from continuing operations was ILS 0.004 compared to ILS 0.021 a year ago. For the nine months, operating income was ILS 10.134 million compared to ILS 17.383 million a year ago. Net loss was ILS 12.989 million compared to ILS 10.732 million a year ago. Basic loss per share from continuing operations was ILS 0.036 compared to ILS 0.051 a year ago.